摘要
目的:对红霉素与阿奇霉素治疗小儿支原体肺炎的临床疗效进行对比分析。方法选取我院于2014年1月~2014年11月收治的34例小儿支原体肺炎患者作为本次的研究对象,把患者随机分成两组,对照组和治疗组分别采用红霉素和阿奇霉素治疗,对两组的治疗效果以及平均住院天数进行对比分析。结果治疗组的治疗总有效率明显高于对照组,并且治疗组患者的平均住院时间明显短于对照组,两组结果对比差异显著,有统计学意义(P〈0.05)。结论使用阿奇霉素治疗小儿支原体肺炎的治疗效果要比红霉素好很多,而且能够缩短患者的住院时间,值得在小儿支原体肺炎的临床治疗中广泛应用。
Objective The erythromycin and azithromycin efficacy in treatment of children patients with mycoplasma pneumonia are to be comparatively analyzed. Methods Choose 34 mycoplasma pneumonia children patients who are treated in hospital from January 2014 to November 2014 and separate them into two groups at random. Patients in control group are given erythromycin treatment,while patients in study group are given azithromycin treatment,and then observe and compare the treatment efficacy as wel as patients’hospitalization days of the two groups. Results The treatment efficiency in study group is much higher than control group;and in addition,the patients’average hospitalization days in study group are less than patients in control group;there is a treatment differential between the two groups,and such a differential has statistic value(P〈0.05). Conclusion Azithromycin is much more effective in treatment of children patients with mycoplasma pneumonia than erythromycin treatment;besides,it is conducive to reducing patients’hospitalization days;thus,azithromycin is quite worthwhile to be promoted and applied clinical y in treatment of children patients with mycoplasma pneumonia.
出处
《中国卫生标准管理》
2015年第9期227-228,共2页
China Health Standard Management
关键词
红霉素
阿奇霉素
小儿支原体肺炎
效果
Erythromycin
Azithromycin
Children patients with mycoplasma pneumonia
Efficacy